-SEC Filing
Codex DNA Says Demonstrates Simple, Scalable, And Cell-Free Approach To Rapid MRNA Vaccine Design And Development At World Vaccine Congress Washington 2022
Codex DNA, Inc. (NASDAQ:DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker presentation for the World Vaccine Congress Washington 2022, which is being held in Washington, DC. on